Heart failure stands out as one of the most fatal cardiovascular diseases, with a 5-year survival rate of only 50% following diagnosis1. As a result, early detection of LVSD is critical, as timely diagnosis along with medication and lifestyle adjustments, can significantly reduce hospitalization and lower the risk of death.
Samsung has overcome this limitation by introducing AI algorithms that were developed in collaboration with Medical AI, a leading Korean medical device company specializing in AI-based ECG technology. These algorithms were developed based on Medical AI’s in-house algorithm for the 12-lead ECG analysis, which is already deployed across over 100 major hospitals in Korea and used for over 120,000 patients on a monthly basis, bringing clinically proven, real-word reliability that led to securing regulatory approval from South Korea’s Ministry of Food and Drug Safety (MFDS) as the first smart watch to gain LVSD detection capabilities.
This technology not only enables early screening for asymptomatic individuals but also aims to reduce the surging healthcare costs associated with heart failure by promoting early diagnosis and timely treatment2. Furthermore, this product aligns with global healthcare priorities, including personalized patient care, proactive health management, lowering healthcare burdens, and advancing the application of AI in medicine.
Our commitment to collaboration extends beyond heart health innovation. Much like the groundbreaking work with Medical AI on LVSD detection, we recently partnered with Hanyang University’s Department of Biomedical Engineering to develop an around-the-ear electroencephalogram(EEG) prototype device, advancing brain-computer interface (BCI) technology with unmatched wearability and precision.
Engineered to overcome limitations of traditional EEG systems, the Ear-EEG offers a sleek, ergonomic design that allows seamless brainwave monitoring outside laboratory settings. Designed to capture high-quality signals with strategically placed electrodes around the ear, the research prototype delivered strong real-world application potential:
This research was recently featured in the Volume 25, Issue 18 of the IEEE Sensors Journal, where it was selected as the sole feature article, further solidifying Samsung’s leadership in wearable sensor innovation.
“This study is a prime example of academia-industry collaboration being recognized internationally for its scholarly significance,” said Professor Chang-Hwan Im of Hanyang University. “The technology we developed is not limited to education and marketing but has the potential to expand into diverse fields such as entertainment and mental health management.”
Through relentless focus on innovation, rigorous research, and ongoing partnerships with world-class experts and institutions, Samsung is redefining the future of healthcare by delivering technologies that are personalized, connected, and more accessible than ever.
Looking ahead, Samsung is poised to redefine the future of healthcare by delivering technologies that are personalized, connected, and accessible to everyone. Through relentless innovation and strategic collaboration, Samsung continues to simplify the wellness journey, offering users the tools they need to proactively manage their health and embrace smarter, healthier lifestyles. This commitment ensures that Samsung’s solutions not only meet the needs of today’s users but also push the boundaries of what’s possible in tomorrow’s healthcare landscape.
1 5년 내 50%가 사망… 암보다 사망률 높은 '이 질환' - 헬스조선
2 *Not intended for use in detection, diagnosis or treatment of any medical condition. Intended for general wellness and fitness purposes only. Please consult a medical professional for advice.
Images (1)